Bio-Works Technologies AB (publ)
SSE:BIOWKS.ST
Overview | Financials
Company Name | Bio-Works Technologies AB (publ) |
Symbol | BIOWKS.ST |
Currency | SEK |
Price | 4.85 |
Market Cap | 189,052,030 |
Dividend Yield | 0% |
52-week-range | 4.7 - 23.5 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jonathan Royce |
Website | https://www.bio-works.com |
An error occurred while fetching data.
About Bio-Works Technologies AB (publ)
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD